BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• FDA

  Janssen-Cilag International NV Release: INVEGA® Receives European Commission Approval To Extend Its Adult Indication For Treatment Of Schizophrenia To Include Adolescents Aged 15 Years And Older

  June 4, 2014

   · 

  1 min read
• Lone Star Bio

  LDR Holding Corporation To Present At The William Blair Growth Conference

  June 4, 2014

   · 

  1 min read
• Pharm Country

  Relburn-Metabolomics To Report Clinical And Scientific Progress In Anti-Gout Program At The European Congress On Rheumatology

  June 4, 2014

   · 

  3 min read
• Genetown

  Insulet Corporation Announces Public Offering Of Convertible Senior Notes

  June 4, 2014

   · 

  3 min read
• Drug Development

  Celator Pharmaceuticals, Inc. Reaches 75 Percent Enrollment Milestone In Phase 3 Study Of CPX-351

  June 4, 2014

   · 

  1 min read
• Biotech Bay

  SteadyMed Announces Raise Of $19.6 Million In Preferred Stock Financing

  June 4, 2014

   · 

  2 min read
• Drug Development

  Kadmon Corporation Announces The Initiation Of A Phase 1b/2a Study Of KD019 And Trastuzumab In HER2-Positive Metastatic Breast Cancer

  June 4, 2014

   · 

  3 min read
• Drug Development

  Advanced Cancer Therapeutics Enters Phase 1 Human Clinical Trials With First-in-Class Anti-Cancer Drug Candidate

  June 4, 2014

   · 

  1 min read
• Biotech Beach

  Ruthigen Announces The Distribution Of Letter To Stockholders

  June 4, 2014

   · 

  7 min read
• Business

  Aastrom Biosciences, Inc. Announces Appointment Of Gerard Michel As Chief Financial Officer And Vice President, Corporate Development

  June 4, 2014

   · 

  1 min read